Clinical Trials Logo

Sleep Disturbance clinical trials

View clinical trials related to Sleep Disturbance.

Filter by:

NCT ID: NCT03150433 Completed - Pain Clinical Trials

Sleep and Pain in Sickle Cell Disease

Start date: November 5, 2017
Phase: N/A
Study type: Interventional

This is a study testing the effects of behavioral sleep interventions on pain and brain function in sickle cell disease.

NCT ID: NCT03144531 Completed - Asthma Clinical Trials

Sleep Intervention for Kids and Parents: A Self-Management Pilot Study

SKIP
Start date: March 1, 2017
Phase: N/A
Study type: Interventional

Behavioral intervention for 6-11 year children with persistent asthma and sleep disturbance and a parent with sleep disturbance.

NCT ID: NCT03114189 Completed - Sleep Disturbance Clinical Trials

Kneipp Water Applications for Insomnia

KWAI
Start date: November 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to ascertain whether warm footbathes are effective on sleep disturbances in women before climacteric.

NCT ID: NCT03114072 Active, not recruiting - Sleep Disturbance Clinical Trials

Blocking Blue Light in Pregnancy, Effects on Melatonin Profile and Sleep

Start date: June 6, 2017
Phase: N/A
Study type: Interventional

Sleep disturbances are common in pregnancy, and the incidence increases during the third trimester. Light and specially the blue wavelengths of light, is affecting sleep and the circadian rhythm. The main aim of this randomized controlled study is to investigate the effect of Blue-blocking glasses (BB-glasses) used in the evening and night on sleep and mood in pregnant women in the third trimester. The outcome measures assess sleep variables, alertness, melatonin level, sleepiness (subjectively), mood and symptoms of anxiety and depression. In addition we want to measure the pregnancy related sleep problems, alcohol intake, physical activity and perceives stress in the study population, and the association with daily/nightly light exposure.

NCT ID: NCT03112824 Completed - Obesity Clinical Trials

Functional Assessment of Ashwagandaha Root Extract During Weight Loss

Start date: October 5, 2017
Phase: N/A
Study type: Interventional

Patients who are involved in a clinical protocol driven 12 week medical weight loss intervention will be randomized to receive either a placebo or 600 mg of an ashwagandha root extract. The study endpoints are primarily the patients self-reported perception of life stress and sleep quality. The working hypothesis of this study is that the addition of aschwagandha to .the medical weight loss program will improve the self-reported perception of life stress and sleep quality

NCT ID: NCT03108599 Recruiting - Fatigue Clinical Trials

Tech4Rest Trial With Team Truck Drivers

Tech4Rest
Start date: May 1, 2017
Phase: N/A
Study type: Interventional

The current project is a safety and health intervention focused on sleep and fatigue among truck driver teams (pairs), where one driver sleeps in a moving vehicle while the other partner drives. This study is conducted within the Oregon Healthy Workforce Center (OHWC), a NIOSH Center of Excellence in Total Worker Health. We will evaluate engineering and behavioral interventions to improve sleep, reduce fatigue, and impact Total Worker Health. An enhanced cab intervention will alter whole body vibrations during driving and sleep periods, and includes a therapeutic mattress system and an active suspension seat. The enhanced cab will be evaluated alone and in combination with a behavioral sleep intervention adapted from our effective SHIFT (Safety &Health Involvement For Truckers) program. The interventions prioritize hazard reduction according to the hierarchy of controls, and will be evaluated with a randomized controlled design.

NCT ID: NCT03087799 Completed - Clinical trials for Irritable Bowel Syndrome

Brief Behavioral Treatment for Sleep Problems in IBS Study

Start date: March 3, 2017
Phase: N/A
Study type: Interventional

Patients with Irritable Bowel Syndrome (IBS) often report more fatigue and sleep disturbances compared to their healthy counterparts and compared to patients with other GI disorders. This pilot study will evaluate the feasibility of a Brief Behavioral Treatment for Insomnia (BBT-I) in Irritable Bowel Syndrome. 40 participants will be recruited; 20 will receive 4 weeks of BBT and 20 will be assigned to a wait list control group (WLC). The primary aim of the current project is to assess feasibility of administering BBT-I to a sample of patients with IBS. Because behavioral sleep treatment has not yet been studied in IBS or any other GI population, this project will provide information about treatment adherence, recruitment, and effect sizes. Secondary aims include evaluating the impact of BBT-I on sleep quality and IBS symptom severity.

NCT ID: NCT03060096 Completed - Cancer Clinical Trials

Stepped-Care Telehealth for Distress in Cancer Survivors

Telehealth
Start date: July 19, 2018
Phase: N/A
Study type: Interventional

Mental health issues in post-treatment adult cancer survivors are associated with multiple adverse outcomes and may represent a cancer health disparity for rural survivors. The purpose of this study is to test a stepped-care approach tailored to symptom severity based on recent American Society of Clinical Oncology guidelines for reducing emotional distress (anxiety and/or depressive symptoms) and improving secondary outcomes (sleep disturbance, fatigue, fear of recurrence, quality of life) in rural, post-treatment cancer survivors in community oncology settings and to examine intervention costs. The resultant intervention will have great potential for widespread dissemination since it will be manualized, delivered by telephone, and comprised of modules to allow customized treatments for individuals with different cancer types.

NCT ID: NCT02954809 Recruiting - Fatigue Clinical Trials

Effects of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors

Start date: October 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effects of morning bright light therapy on fatigue, sleep disturbances, and circadian activity rhythms in lung cancer survivors.

NCT ID: NCT02939586 Completed - Sleep Clinical Trials

The Effect of Haemodialysis in Sleep Apnoea

Start date: October 2016
Phase: N/A
Study type: Interventional

Sleep disturbance is a significant issue in people undergoing dialysis. More than 80% of haemodialysis patients complain of difficulty sleeping. Inadequate sleep can cause poor daytime function and increased risk of motor vehicle incidents. One of the common reasons for sleep disturbance in dialysis patients is sleep apnoea. Sleep apnoea involves pauses in breathing that occur during sleep. Each pause can last only a few seconds or minutes. Severe sleep apnoea reduces oxygen supply and increases risk of heart attack and stroke, which are the leading causes of death in dialysis patients. In this project, the investigators will examine how a change of dialysis treatment might improve sleep. This project will first identify patients at risk of sleep disturbance using surveys and a subsequent sleep study. The investigators will then test different dialysis models to see the effect of dialysis treatment on sleep apnoea. The aim is to find a dialysis model that works better for patients with sleep apnoea.